Crispr Therapeutics AG (NASDAQ:CRSP) reported 12/31/2018 earnings this Morning, coming in at ($0.92) per share, missing Wall Street’s estimates of ($0.78) per Share. Revenue for the quarter came in at $0.10 million missing the streets estimates of $1.56 million
Recent Trading for Crispr Therapeutics AG (NASDAQ:CRSP)
Shares of Crispr Therapeutics AG closed the previous trading session at 39.23 up +7.56 23.87% with 2119441 shares trading hands.